https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381924/full
Frontiers | Editorial: Cardiorenal disease: a practical approach
Heart failure and chronic kidney disease are among the most common comorbidities in the population. Often, both diseases coexist in the same patient, with a ...
frontierseditorialcardiorenaldiseasepractical
https://pmc.ncbi.nlm.nih.gov/articles/PMC8442438/
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of...
A meta-analysis is presented of cardiovascular outcome trials (CVOTs) comparing glucagon-like peptide-1 receptor agonists (GLP-1RA) versus placebo on...
https://www.themuse.com/jobs/csl/director-sr-global-regulatory-lead-cardiorenal
Director, Sr. Global Regulatory Lead - Cardiorenal at CSL | The Muse | The Muse
Find our Director, Sr. Global Regulatory Lead - Cardiorenal job description for CSL located in Zurich, Switzerland, as well as other career opportunities that...
global regulatorydirectorsrleadcardiorenal
https://www.dcrmi.com/
Home | Diabetes Cardiorenal & Metabolism Institute
diabetescardiorenalmetabolisminstitute
https://pmc.ncbi.nlm.nih.gov/articles/PMC9624240/
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and...
SGLT2 (sodium-glucose cotransporter 2) inhibitors produce a distinctive pattern of benefits on the evolution and progression of cardiomyopathy and nephropathy,...
of thesglt2 inhibitorscriticalreanalysismechanisms
https://www.booktopia.com.au/cardiorenal-syndrome-adel-e-berbari/book/9788847014626.html
Cardiorenal Syndrome by Adel E. Berbari | Mechanisms, Risk and Treatment | 9788847014626 | Booktopia
Buy Cardiorenal Syndrome, Mechanisms, Risk and Treatment by Adel E. Berbari from Booktopia. Get a discounted Hardcover from Australia's leading online...
cardiorenal syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC7082467/
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established...
Linagliptin, a dipeptidyl peptidase-4 inhibitor, demonstrated cardiovascular and renal safety in type 2 diabetes mellitus (T2DM) patients with established...
type 2 diabetes mellitus
https://www.ohsu.edu/school-of-medicine/nephrology-and-hypertension/cardiorenal-program
Cardiorenal Program | OHSU
In the OHSU Cardiorenal Program, we care for patients with complex heart and kidney disease.
cardiorenalprogramohsu
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2014/05/21/00/08/CARRESS-HF
Cardiorenal Rescue Study in Acute Decompensated Heart Failure - American College of Cardiology
decompensated heart failurestudy in
https://www.mdpi.com/2077-0383/12/19/6285
Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
Nonsteroidal mineralocorticoid receptor antagonists (MRAs) present a promising therapeutic option in cardiorenal diseases, mitigating the limitations of...
mineralocorticoid receptornonsteroidalantagonistfinerenonecardiorenal
https://pmc.ncbi.nlm.nih.gov/articles/PMC11546376/
NAD+ enhancers as therapeutic agents in the cardiorenal axis - PMC
Cardiorenal diseases represent a complex interplay between heart failure and renal dysfunction, being clinically classified as cardiorenal syndromes (CRS)....
therapeutic agentsnadenhancerscardiorenalaxis
https://pmc.ncbi.nlm.nih.gov/articles/PMC7704862/
Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally-Induced Cardiorenal...
Sacubitril/Valsartan (Sac/Val), a combined angiotensin-II receptor blocker (Val) and neprilysin inhibitor (Sac) in a 1:1 molar ratio, was shown to reduce the...
effectsangiotensinneprilysininhibition
https://www.mendeley.com/catalogue/90cd87b2-5b70-3281-bc6c-dff69440ca9d/
Cardiorenal Syndrome in Right Hea... preview & related info | Mendeley
(2025) Ichimura et al. Cardiovascular Drugs and Therapy. Cardiorenal syndrome (CRS) due to right ventricular (RV) failure is a disease entity emerging as a key...
cardiorenal syndromerelated inforightheapreview
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.1008517/full
Frontiers | The molecular mechanisms and intervention strategies of mitophagy in cardiorenal...
Cardiorenal syndrome (CRS) is defined as a disorder of the heart and kidney, in which acute or chronic injury of one organ may lead to acute or chronic dysfu...
molecular mechanismsintervention strategiesfrontiers
https://www.mdpi.com/1999-4915/16/4/542
Mechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV
Chronic anemia is more prevalent in people living with HIV (PLWH) compared to the general population. The mechanisms that drive chronic anemia in HIV are...
chronic anemiain peoplemechanismscardiorenalcomplications
https://www.elsevier.es/en-revista-clinica-e-investigacion-arteriosclerosis-english-415-articulo-cardiorenal-syndrome-as-predictor-in-hospital-S252991231800030X
Cardiorenal syndrome as predictor of in-hospital mortality in ST-segment elevation myocardial...
BackgroundCardiorenal syndrome includes numerous conditions affecting the heart and kidney, and
st segment elevationcardiorenal syndromein hospital
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2015/10/05/15/45/Competing-Risk-of-Cardiac-Status-and-Renal-Function
Cardiorenal Function in Heart Failure - American College of Cardiology
heart failureamerican collegecardiorenalfunctioncardiology